ITMO
ru/ ru

ISSN: 1023-5086

ru/

ISSN: 1023-5086

Scientific and technical

Opticheskii Zhurnal

A full-text English translation of the journal is published by Optica Publishing Group under the title “Journal of Optical Technology”

Article submission Подать статью
Больше информации Back

УДК: 616.13.002.2-004.6

Thermography and ultrasound in the evaluation of smoking as a risk factor of cardiovascular pathology

For Russian citation (Opticheskii Zhurnal):

Стулин И.Д., Гуревич К.Г., Солонский Д.С., Мусин Р.С., Мнушкин А.О., Сазонова А.Г., Лочан Н.В., Лысейко Н.В., Мацкеплишвили М.Т., Труханов С.А., Кощеев А.В., Селезнев Ф.А., Стулина Д.Д. Термография и ультразвук в оценке курения как фактора риска сердечно-сосудистой патологии // Оптический журнал. 2013. Т. 80. № 6. С. 68–72.

 

Stulin I.D., Gurevich K.G., Solonskiy D.S., Musin R.S., Mnushkin A.O., Sazonova A.G., Lochan N.V., Lyseyko N.V., Matskeplishvili M.T., Trukhanov S.A., Koshcheev A.V., Seleznev F.A., Stilina D.D. Thermography and ultrasound in the evaluation of smoking as a risk factor of cardiovascular pathology [in Russian] // Opticheskii Zhurnal. 2013. V. 80. № 6. P. 68–72.

For citation (Journal of Optical Technology):

I. D. Stulin, K. G. Gurevich, D. S. Solonskiĭ, R. S. Musin, A. O. Mnushkin, A. G. Sazonova, N. V. Lochan, N. V. Lyseĭko, M. T. Matskeplishvili, S. A. Trukhanov, A. V. Koshcheev, F. A. Seleznev, and D. D. Stulina, "Thermography and ultrasound in the evaluation of smoking as a risk factor of cardiovascular pathology," Journal of Optical Technology. 80(6), 379-381 (2013). https://doi.org/10.1364/JOT.80.000379

Abstract:

This paper is devoted to a study of the vasospastic and atherogenic effects of nicotine. One hundred twenty students were examined, half of which had been smokers for more than two years. Telethermography, ultrasound dopplerography, and duplex scanning were carried out on volunteers. It is shown that smoking has distinct vasospastic and atherogenetic effects. This article also discusses the prospects of a more extensive two-stage catamnestic investigation.

Keywords:

atherosclerosis, smoking, thermography, telethermography, ultrasound dopplerography, duplex scanning

OCIS codes: 110.3080, 170.7180, 170.3880

References:

1. World Health Organization, WHO Global Report: Mortality Attributable to Tobacco (WHO Press, Switzerland, 2012).
2. World Health Organization, World Health Statistics 2012 (France, 2012).
3. N. A. Pryanikova, L. V. Stakhovskaya, V. I. Skvortsova, K. S. Meshkova, and K. V. Shekhovtsova, “How to correctly choose an antiaggregant for secondary prophylaxis of ischemic insult,” Consilium Medicum No. 2, 68 (2007).
4. S. A. Shal’nova, A. D. Deev, and R. G. Oganov, “Factors that influence the morbidity cardiovascular illnesses in the Russian population,” Kardiovaskulyarnaya Terapiya i Profilaktika No. 4(1), 4 (2005).
5. S. E. Vollset, A. Tverdal, and K. H. Gjessing, “Smoking and deaths between 40 and 70 years of age in women and men,” Ann. Intern. Med. 144, 381 (2006).
6. “Concept of carrying out the state policy of counteracting the demand for tobacco in 2010–2015: resolved by the order of the government of the Russian Federation on September 23, 2010,” No. 1563, Collection of Legislation of the Russian Federation, 10/4/2010, No. 40, p. 5118.
7. “Concerning the specialization of methodological recommendations on the indication of medical assistance of the adult population on preventing and giving up smoking,” Pis’mo Minzdrav. Rossii from 5/5/2012 N 14-3/10/12817, http://www.rosminzdrav.ru/docs/mzsr/spa/143.
8. K. Karatzi, C. Papamichael, E. Karatzis, T. G. Papaioannou, K. Stamatelopoulos, N. A. Zakopoulos, A. Zampelas, and J. Lekakis, “Acute smoke-induced endothelial dysfunction is more prolonged in smokers than in non-smokers,” Int. J. Cardiol. 120, 404 (2007).
9. V. A. Karlov, I. D. Stulin, and Yu. N. Bogin, Ultrasound and Thermal-Vision Diagnosis of Vascular Diseases of the Nervous System, (Meditsina, Moscow, 1986).
10. M. Aschermann, “Atherosclerosis in childhood,” Časopis Lekaru Českych. 148, No. 8, 155 (2009).